Steffen Uffenorde/LinkedIn
Sep 7, 2026, 16:27
Steffen Uffenorde: WHO Consolidated Guidelines for SCD in Children and Adolescents
Steffen Uffenorde, Head of Market Access and Health Economics, Europe and Middle East at Terumo Blood and Cell Technologies; University Lecturer for International HTA, Pricing and Reimbursement, Pharmacoeconomic Evaluation at Hochschule Fresenius, shared a post on LinkedIn:
“WHO consolidated guidelines for the management of Sickle Cell Disease in children and adolescents.
The guideline notes: ‘The choice between exchange and simple RBC transfusion should be guided by clinical urgency, local resource availability and the potential for improved outcomes with exchange transfusion’.”
Stay updated with Hemostasis Today.
-
Sep 7, 2026, 18:36Richard Kollen: Preventing Deep Vein Thrombosis During Long Flights
-
Sep 7, 2026, 18:34Mahmoud Hashem: Apixaban – Doses According to the Reason for Use
-
Sep 7, 2026, 14:44Abdel Gaffar Mohammed: Treatment Approaches for Different Types of TMA
-
Sep 7, 2026, 18:31Julian P. Villacastin: LAAC as a Treatment Option When Long-Term Anticoagulation Is Problematic
-
Sep 7, 2026, 18:29Geoff Stooke: How Hemophilia Led the Massie Family to the Romanovs and Ronald Reagan
-
Sep 7, 2026, 18:27Sam Mbunya: September is Sickle Cell Awareness Month
-
Sep 7, 2026, 18:25David Akande: Things I Wish People Knew About Sickle Cell
-
Sep 7, 2026, 18:24Prachi Bansal: A Small Act of Giving, A Lifelong Lesson in Humanity
-
Sep 7, 2026, 17:27Isaac Okello: From Global Dialogue to Local Impact in Sickle Cell Disease